Synthesis and anti-HIV activity of 1,3-dithiolane nucleosides

Abstract

References

1. H. Mitsuya, J. K. Weinhold, P. A. Furman, M. H. St-Clair, S. Nusinoff-Lehrman, R. C. Gallo, D. Bolognesi, D. W. Barry and S. Broder, Proc. Natl. Acad. Sci. U.S.A., 1985, 82, 7096.
2. H. Mitsuya and S. Broder, Proc. Natl. Acad. Sci. U.S.A., 1986, 83, 1911; R. Yarchoan, H. Mitsuya, R. V. Thomas, J. M. Pluda, N. R. Hartman, C.-F. Perno, K. S. Marczyk, J.-P. Allain, D. G. Johns and S. Broder, Science, 1989, 245, 412; T.-S. Lin, R. F. Schinazi and W. H. Prusoff, Biochem. Pharmacol., 1987, 36, 2713.
3. (a) R. W. Klecker, J. M. Collins, R. Yarchoan, R. Thomas, J. F. Jenkins, S. Broder and C. E. Myers Cli, Pharmacol. Ther., 1987, 47, 407; (b) M. S. Hirsch and J. C. Kaplan, Antimicrob. Agents Chemother., 1987, 31, 939; (c) R. Yarchoan, Lancet, 1988, i, 76; (d) M. L. Peterson and R. Vince, J. Med. Chem., 1991, 34, 2787 and references cited therein.
4. (a) B. Belleau, L. Brasili, L. Chan, M. D. DiMarco, B. Zacharie, N. Nguyen-Ba, H. J. Jenkinson, J. A. V. Coates and J. M. Cameron, Bioorg. Med. Chem. Lett., 1993, 3, 1723; (b) M. J. Bamford, D. C. Humber and R. Storer, Tetrahedron Lett., 1991, 32, 271 and references cited therein; (c) J. Branalt and I. Kvarnstrom, J. Org. Chem., 1996, 61, 3604 and references cited therein.
5. (a) T. S. Mansour, C. A. Evans, M. A. Siddiqui, M. Charron, B. Zacharie, N. Nguyen-Ba, N. Lee and B. Korba, Nucleosides Nucleotides, 1997, 16, 993; (b) H. Soudeyns, X. J. Yao, Q. Gao, B. Belleau, J.-L. Kraus, N. Nguyen-Ba, B. Spira and M. A. Wainberg, Antimicrob. Agents Chemother., 1991, 35, 1386; (c) J. A. V. Coates, N. Cammack, H. J. Jenkinson, I. M. Mutton, B. A. Pearson, R. Storer, J. M. Cameron and C. R. Penn, Antimicrob. Agents Chemother., 1992, 36, 202; (d) M. W. Chun, D. H. Shin, H. R. Moon, J. Lee, H. Park and L. S. Jeong, Bioorg. Med. Chem. Lett., 1997, 7, 1475.
6. U.S. Pat. 05047407, BioChem Pharma Inc:; M. A. Nowak, S. Bon Hoeffer, A. M. Hill, R. Bochme, H. C. Thomas and H. McDade, Proc. Natl. Acad. Sci. U.S.A., 1996, 93, 4398.
7. J. A. Secrist III, K. N. Tiwari, A. T. Shortnacy-Fowler, L. Messini, J. M. Riordan and J. A. Montgomery, J. Med. Chem., 1998, 41, 3865; M. R. Dyson, P. L. Coe and R. T. Walker, J. Med. Chem., 1991, 34, 2782.
8. H. Vorbruggen, K. Krolikiewicz and B. Bennua, Chem. Ber., 1981, 114, 1234.
9. N. Nguyen-Ba, W. Brown, N. Lee and B. Zacharie, Synthesis, 1998, 759.
10. M. Therien, J. Y. Gauthier and R. N. Young, Tetrahedron Lett., 1988, 29, 6733.
11. J. Y. Gauthier, T. Henien, L. Lo, M. Therien and R. N. Young, Tetrahedron Lett., 1988, 29, 6729.
12. J. M. Cameron, P. Collis, M. Daniel, R. Storer and P. Wilcox, Drugs Future, 1993, 18, 319 and references cited therein.
13. L. W. Frick, L. St-John, L. C. Taylor, G. R. Painter, P. A. Furman, D. C. Liotta, E. S. Furfine and D. J. Nelson, Antimicrob. Agents Chemother., 1993, 37, 2285.
14. Chiral Column: Cyclobond I 2000 Beta-RSP 4.6 mm ID × 250 mm; mobile phase 10% MeCN–0.05%(AcOH–Et₃N, pH 6.74); pressure 965 psi and flow rate 0.50 ml min^–1. For 26: t_R= 19.880 min; for 27: t_R= 22.201 min.